Header Logo

Connection

Mayer Davidson to Non-alcoholic Fatty Liver Disease

Back to Details
This is a "connection" page, showing publications Mayer Davidson has written about Non-alcoholic Fatty Liver Disease.
Mayer Davidson
Connection Strength
0.550
Non-alcoholic Fatty Liver Disease
  1. An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug's effect on cardiovascular disease and non-alcoholic steatohepatitis. Diabetes Res Clin Pract. 2018 Jan; 135:102-110.
    View in: PubMed
    Score: 0.550
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.